Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic mela... by Igor V. Samoylenko, Lev V. Demidov, Fedor V. Moiseenko, Mikhail V. Dvorkin, Svetlana A. Demidova, Svetlana A. Protsenko, Daniil L. Stroyakovskiy, Vadim V. Kozlov, Svetlana V. Odintsova, Dmitry V. Kirtbaya, Denis A. Tantsyrev, Anastasia S. Mochalova, Rashida V. Orlova, Guzel Z. Mukhametshina, Natalia V. Fadeeva, Evgeny A. Fomin, Yana S. Chapko, Anna V. Tarasova, Nikolay B. Ermakov, Alexander K. Shemerovskiy, Vera A. Vaschenko, Valery M. Chistyakov, Arina V. Zinkina-Orikhan, Yulia N. Lin'kova, Fedor B. Kryukov, Irina V. Sorokina, Anna A. Siliutina

Get full text